Lisata Therapeutics, Inc.
LSTA
$1.95
-$0.0575-2.86%
| Weiss Ratings | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.37 | |||
| Price History | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.66% | |||
| 30-Day Total Return | -18.69% | |||
| 60-Day Total Return | -46.39% | |||
| 90-Day Total Return | -30.80% | |||
| Year to Date Total Return | -45.34% | |||
| 1-Year Total Return | -35.81% | |||
| 2-Year Total Return | -36.64% | |||
| 3-Year Total Return | -81.28% | |||
| 5-Year Total Return | -94.09% | |||
| 52-Week High % Change | -52.17% | |||
| 52-Week Low % Change | 7.43% | |||
| Price | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.20 | |||
| 52-Week Low Price | $1.87 | |||
| 52-Week Low Price (Date) | Apr 07, 2025 | |||
| 52-Week High Price (Date) | Jan 06, 2025 | |||
| Valuation | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 16.89M | |||
| Enterprise Value | -14.47M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.40 | |||
| Earnings Per Share Growth | -6.93% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 16.87 | |||
| Price/Book (Q) | 0.57 | |||
| Enterprise Value/Revenue (TTM) | -14.47 | |||
| Price | $1.95 | |||
| Enterprise Value/EBITDA (TTM) | 0.65 | |||
| Enterprise Value/EBIT | 0.65 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 8.40M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 908 842 0100 | |||
| Address | 110 Allen Road Basking Ridge, NJ 07920 | |||
| Website | www.lisata.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2,240.90% | |||
| Profit Margin | -1,998.50% | |||
| Management Effectiveness | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -31.23% | |||
| Return on Equity | -- | |||
| Income Statement | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.00M | |||
| Total Revenue (TTM) | 1.00M | |||
| Revenue Per Share | $0.12 | |||
| Gross Profit (TTM) | 1.00M | |||
| EBITDA (TTM) | -22.24M | |||
| EBIT (TTM) | -22.41M | |||
| Net Income (TTM) | -19.99M | |||
| Net Income Avl. to Common (TTM) | -19.99M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 14.07% | |||
| EPS Diluted (TTM) | -2.40 | |||
| EPS Diluted Growth (Q YOY) | 16.66% | |||
| Balance Sheet | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 31.25M | |||
| Cash Per Share (Q) | $3.72 | |||
| Total Current Assets (Q) | 34.58M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 29.32M | |||
| Current Ratio (Q) | 6.160 | |||
| Book Value Per Share (Q) | $3.52 | |||
| Total Assets (Q) | 35.00M | |||
| Total Current Liabilities (Q) | 5.61M | |||
| Total Debt (Q) | 137.00K | |||
| Total Liabilities (Q) | 5.69M | |||
| Total Common Equity (Q) | 29.57M | |||
| Cash Flow | LSTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 13.23M | |||
| Cash from Financing (TTM) | -206.00K | |||
| Net Change in Cash (TTM) | -6.38M | |||
| Levered Free Cash Flow (TTM) | -13.07M | |||
| Cash from Operations (TTM) | -19.36M | |||
